Drug Profile
BAY 1007626
Alternative Names: Progestin IUS - BayerLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare
- Class Hormonal contraceptives; Progesterone congeners
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 28 Sep 2021 Discontinued - Phase-II for Pregnancy (Prevention) in Netherlands, Germany, United Kingdom (Intrauterine) (Bayer Healthcare pipeline, September 2021)
- 01 Nov 2018 Progestin is still in phase II trials for Pregnancy (Prevention) in Germany, Netherlands and United Kingdom (Bayer pipeline, October 2018)
- 01 Jul 2016 Bayer terminates a phase II trial in Contraception in Germany, Netherlands and United Kingdom (Intrauterine) (NCT02490774)